Chronic bronchitis

Last updated: February 23, 2023

Chronic bronchitis

RHS

RHS

Viral structure and functions
Rhinovirus
Adenovirus
Influenza virus
Human parainfluenza viruses
Respiratory syncytial virus
Staphylococcus aureus
Streptococcus viridans
Streptococcus pyogenes (Group A Strep)
Streptococcus pneumoniae
Corynebacterium diphtheriae (Diphtheria)
Enterococcus
Upper respiratory tract infection
Allergic rhinitis
Bacillus anthracis (Anthrax)
Nocardia
Enterobacter
Yersinia enterocolitica
Pseudomonas aeruginosa
Klebsiella pneumoniae
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Bacteroides fragilis
Yersinia pestis (Plague)
Moraxella catarrhalis
Francisella tularensis (Tularemia)
Bordetella pertussis (Whooping cough)
Haemophilus influenzae
Pasteurella multocida
Mycobacterium tuberculosis (Tuberculosis)
Mycobacterium leprae
Mycobacterium avium complex (NORD)
Mycoplasma pneumoniae
Chlamydia pneumoniae
Coxiella burnetii (Q fever)
Epstein-Barr virus (Infectious mononucleosis)
Human herpesvirus 6 (Roseola)
Human herpesvirus 8 (Kaposi sarcoma)
Parvovirus B19
Mumps virus
Measles virus
Zika virus
Rubella virus
Candida
Plasmodium species (Malaria)
Asthma: Clinical
Pneumonia
Pneumonia: Pathology review
Respiratory distress syndrome: Pathology review
Restrictive lung diseases
Restrictive lung diseases: Pathology review
Sarcoidosis
Hypersensitivity pneumonitis
Obstructive lung diseases: Pathology review
Tuberculosis: Pathology review
Type IV hypersensitivity
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Sinusitis
Laryngitis
Retropharyngeal and peritonsillar abscesses
Bacterial epiglottitis
Congenital pulmonary airway malformation
Acute respiratory distress syndrome
Emphysema
Asthma
Bronchiectasis
Cystic fibrosis
Alpha 1-antitrypsin deficiency
Chronic bronchitis
Idiopathic pulmonary fibrosis
Lung cancer
Superior vena cava syndrome
Pancoast tumor
Pneumothorax
Mesothelioma
Pleural effusion
Pulmonary embolism
Pulmonary hypertension
Pulmonary edema
Cystic fibrosis: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Lung cancer and mesothelioma: Pathology review
Iron deficiency anemia
Beta-thalassemia
Alpha-thalassemia
Sideroblastic anemia
Anemia of chronic disease
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Sickle cell disease (NORD)
Aplastic anemia
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Acute intermittent porphyria
Hemophilia
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Immune thrombocytopenia
Von Willebrand disease
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Myelodysplastic syndromes
Polycythemia vera (NORD)
Myelofibrosis (NORD)
Essential thrombocythemia (NORD)
Mastocytosis (NORD)
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Bronchioles and alveoli histology
Trachea and bronchi histology
Lung volumes and capacities
Alveolar surface tension and surfactant
Ventilation
Zones of pulmonary blood flow
Regulation of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Airflow, pressure, and resistance
Gas exchange in the lungs, blood and tissues
Diffusion-limited and perfusion-limited gas exchange
Blood histology
Blood components
Erythropoietin
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Antimalarials

Transcript

Watch video only

Content Reviewers

Bronchitis means inflammation of the bronchial tubes in the lung, and it’s said to be chronic when it causes a productive cough—which means produces mucus—for at least 3 months each year for 2 or more years.

Chronic bronchitis is actually lumped under the umbrella of chronic obstructive pulmonary disease (or COPD), along with emphysema.

These two are different in that chronic bronchitis is defined by clinical features, like a productive cough, whereas emphysema is defined by structural changes—specifically enlargement of the air spaces.

That being said, they often coexist, probably because they share the same major risk factor — smoking.

Other risk factors for chronic bronchitis include exposure to air pollutants like sulfur and nitrogen dioxide, exposure to dust and silica, as well as genetic factors like having a family history of chronic bronchitis.

With COPD, the airways become obstructed, and the lungs don’t empty properly, and that leaves air trapped inside the lungs.

For that reason, the maximum amount of air people with COPD can breath out in a single breath, known as the FVC, or forced vital capacity, is lower.

This reduction is especially noticeable in the first second of air breathed out in a single breath, called FEV1forced expiratory volume (in one second), which typically is reduced even more than the FVC.

A useful metric therefore is the FEV1 to FVC ratio, which, since the FEV1 goes down even more than FVC, causes the FEV1 to FVC ratio to go down as well.

Alright so say normally your FVC is 5 L, and your FEV1 is 4 L, your FEV1 to FVC ratio would end up being 80%.

Now, someone with COPD’s FVC might be 4 L instead, which is lower than normal, but the volume of air that he or she can expire in the first second is only 2 L, so not only are both these values lower, but their ratio is lower as well—and this is a hallmark of COPD.

All that had to do with air breathed out right? Conversely, for air going in, the TLC, or total lung capacity, which is the maximum volume of air that can be taken in or inspired into the lungs, is actually often often higher because of the air trapping.

Alright, so chronic bronchitis is a type of COPD that’s diagnosed based on clinical symptoms, specifically coughing up a lot of mucus. But why does this happen?

Well, first off, in the lungs, the walls of normal airways have a couple layers to think about.

Lining the lumen of the airways you’ve got the epithelium, composed of ciliated pseudostratified columnar epithelial cells, which are named that because these epithelial cells have hair-like projections called cilia, their nuclei don’t align so it looks like they’re more than one layer even though they’re not, hence, pseudostratified, and because the cells are mostly tall and narrow - or columnar in shape.

This layer also contains the occasional Goblet cell which makes some of the mucus that lines the airway.

Going deeper past that layer you’ve got the basement membrane and loose connective tissue, called the lamina propria—which together with the epithelium makes up the mucosa.

Beyond the mucosa, there is smooth muscle followed by more connective tissue, and together, these two layers make up the submucosa and this is where the bronchial mucinous glands live.

These are the glands that secrete the majority of the mucus into the lumen of the bronchi, helping to catch and filter out particles and pathogens.

Finally, in the bronchi, but not the bronchioles, there is also a layer of cartilage below the submucosa which stiffens the bronchus and helps to keep it open.

Alright so people who smoke expose their airways to all sorts of irritants and chemicals. Whatever the irritants are, their effect is to stimulate hypertrophy and hyperplasia of the mucinous glands in the main bronchi, as well as the goblet cells in the smaller airways - the bronchioles, which increases mucus production in both locations.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report" Respirology (2017)
  6. "Breathing exercises for chronic obstructive pulmonary disease" Cochrane Database of Systematic Reviews (2012)
  7. "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease" American Journal of Respiratory and Critical Care Medicine (2013)